Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice.
Saved in:
| Title: | Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice. |
|---|---|
| Authors: | Butrón‐Bris, B.1 (AUTHOR), Llamas‐Velasco, M.1 (AUTHOR), Ovejero‐Benito, M. C.2 (AUTHOR), Santos‐Juanes, J.3,4 (AUTHOR), Martínez‐López, A.5 (AUTHOR), Ruiz‐Villaverde, R.6 (AUTHOR), Roustan, G.7 (AUTHOR), Baniandrés, O.8 (AUTHOR), Izu‐Belloso, R.9 (AUTHOR), de la Cueva, P.10 (AUTHOR), Sahuquillo‐Torralba, A.11 (AUTHOR), Gónzalez‐Quesada, A.12 (AUTHOR), Vilarrasa‐Rull, E.13 (AUTHOR), Pujol‐Montcusí, J.14 (AUTHOR), García‐Martínez, J.15 (AUTHOR), Navares, M.16 (AUTHOR), Palomar‐Moreno, I.17 (AUTHOR), Novalbos, J.16 (AUTHOR), Abad‐Santos, F.16 (AUTHOR), Daudén, E.1 (AUTHOR) |
| Source: | Experimental Dermatology. Aug2024, Vol. 33 Issue 8, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
